Loading...
The Procter & Gamble Company
PG•NYSE
Consumer DefensiveHousehold & Personal Products
$163.98
$1.18(0.72%)
The Procter & Gamble Company (PG) Financial Performance & Statements
Review The Procter & Gamble Company’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
2.48%
↑ 2.48%
Operating Income Growth
2.27%
↑ 2.27%
Net Income Growth
1.54%
↑ 1.54%
Operating Cash Flow Growth
17.79%
↑ 17.79%
Operating Margin
23.81%
↑ 23.81%
Gross Margin
51.29%
↑ 51.29%
Net Profit Margin
18.46%
↑ 18.46%
ROE
30.15%
↑ 30.15%
ROIC
22.52%
↑ 22.52%
The Procter & Gamble Company (PG) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for The Procter & Gamble Company stock.
| Metric | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|
| Revenue | $21.88B | $21.74B | $20.53B | $20.20B |
| Cost of Revenue | $10.42B | $10.42B | $10.35B | $9.86B |
| Gross Profit | $11.46B | $11.32B | $10.18B | $10.34B |
| Gross Profit Ratio | $0.52 | $0.52 | $0.50 | $0.51 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $5.72B | $5.52B | $6.30B | $5.88B |
| Operating Expenses | $5.72B | $5.52B | $6.30B | $5.88B |
| Total Costs & Expenses | $16.14B | $15.97B | $16.65B | $15.73B |
| Interest Income | $119.00M | $135.00M | $107.00M | $104.00M |
| Interest Expense | $240.00M | $238.00M | $220.00M | $233.00M |
| Depreciation & Amortization | $706.00M | $728.00M | $761.00M | $712.00M |
| EBITDA | $6.79B | $6.18B | $4.85B | $5.53B |
| EBITDA Ratio | $0.31 | $0.28 | $0.24 | $0.27 |
| Operating Income | $5.74B | $5.80B | $3.88B | $4.46B |
| Operating Income Ratio | $0.26 | $0.27 | $0.19 | $0.22 |
| Other Income/Expenses (Net) | $104.00M | -$657.00M | -$15.00M | $132.00M |
| Income Before Tax | $5.84B | $5.14B | $3.87B | $4.59B |
| Income Before Tax Ratio | $0.27 | $0.24 | $0.19 | $0.23 |
| Income Tax Expense | $1.19B | $1.15B | $726.00M | $812.00M |
| Net Income | $4.63B | $3.96B | $3.14B | $3.75B |
| Net Income Ratio | $0.21 | $0.18 | $0.15 | $0.19 |
| EPS | $1.94 | $1.65 | $1.30 | $1.56 |
| Diluted EPS | $1.88 | $1.58 | $1.27 | $1.52 |
| Weighted Avg Shares Outstanding | $2.35B | $2.36B | $2.47B | $2.36B |
| Weighted Avg Shares Outstanding (Diluted) | $2.46B | $2.47B | $2.47B | $2.47B |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan